Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.5820
-0.04-6.73%
At close: -
$0.5933
0.011.94%
After Hours: Apr 4, 7:28 PM EDT
Comments
Loading...
Spero Therapeutics (SPRO) Forecast
NewsEarningsSpero Therapeutics (SPRO) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Spero Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:SPRO | Benzinga
Explore Spero Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SPRO.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Spero Therapeutics (SPRO) stock?
You can purchase shares of Spero Therapeutics (NASDAQ:SPRO) through any online brokerage.
Who are Spero Therapeutics (SPRO) competitors?
Other companies in Spero Therapeutics’s space includes: Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), Connect Biopharma Hldgs (NASDAQ:CNTB), Coeptis Therapeutics (NASDAQ:COEP) and Barinthus Biotherapeutics (NASDAQ:BRNS).
What is the forecast, or price target, for Spero Therapeutics (SPRO) stock?
Spero Therapeutics has a consensus price target of $4.00.
What is the current price for Spero Therapeutics (SPRO)?
The stock price for Spero Therapeutics (NASDAQ: SPRO) is $0.5933 last updated April 4, 2025 at 7:28 PM EDT.
Does Spero Therapeutics (SPRO) pay a dividend?
A quarterly cash dividend of 0.01 per share of Class A Common Stock. The quarterly cash dividend was payable on October 7, 2015 to stockholders of record on September 16, 2015.
When is Spero Therapeutics (NASDAQ:SPRO) reporting earnings?
Spero Therapeutics’s Q1 earnings are confirmed for Wednesday, May 14, 2025.
Is Spero Therapeutics (SPRO) going to split?
There is no upcoming split for Spero Therapeutics.
What sector and industry does Spero Therapeutics (SPRO) operate in?
Spero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.